Related Experiment Video
Updated: Jun 3, 2026
05:35
A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level
Published on: January 19, 2024
Can ISSWM be used for making treatment decisions?
Pierre Morel1, Giampaolo Merlini
1Service d'Hématologie, Centre hospitalier Schaffner, Lens, France. pmorel@ch-lens.fr
Clinical Lymphoma, Myeloma & Leukemia
|April 2, 2011
Summary
The International Scoring System for WM (ISSWM) predicts survival in Waldenstrom macroglobulinemia patients treated with first-line therapy. This review assesses its clinical applicability for treatment decisions in this rare disease.
Area of Science:
- Hematology
- Oncology
- Clinical Research
Background:
- Waldenstrom macroglobulinemia (WM) is a rare B-cell lymphoproliferative disorder.
- Accurate prognostication is crucial for guiding treatment decisions in WM.
- The International Scoring System for WM (ISSWM) was developed to predict survival.
Purpose of the Study:
- To evaluate the clinical utility of the ISSWM for treatment decision-making in WM.
- To assess the applicability of this prognostic model in the context of a rare disease.
Main Methods:
- Review of the ISSWM model, which incorporates age, hemoglobin, platelet count, serum β2-microglobulin, and monoclonal protein levels.
- Analysis of the model's predictive accuracy for survival based on reported five-year survival rates: 87% (low-risk), 68% (intermediate-risk), and 36% (high-risk).
Main Results:
- The ISSWM demonstrates distinct five-year survival rates across risk groups.
- The model's applicability in clinical practice for treatment decisions is discussed, acknowledging challenges in rare diseases.
Conclusions:
- The ISSWM is a valuable tool for predicting survival in Waldenstrom macroglobulinemia patients.
- Reporting ISSWM subgroup distribution in treatment studies is recommended for enhanced clinical interpretation and comparability.
Related Concept Videos
01:15Methods of Documentation VI: Case Management Model
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic illness...
For example, a patient with a chronic illness...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:12Statistical Software for Data Analysis and Clinical Trials
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
01:27Nursing Clinical Information System
Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...